Bone loss in metabolic acidosis is a long-known phenomenon [28,29] attributable to a direct effect of extracellular protons on osteoclasts, osteoblasts and matrix proteins and an indirect effect via deregulation of the growth hormone/IGF-axis and elevated glucocorticoids [9,10,30]. The gene discussed is IGF1; the disease is acidosis disorder.